Reuters logo
BRIEF-Bone Therapeutics reports strong interim results from ALLOB phase IIa spinal fusion study
September 14, 2017 / 5:08 AM / 12 days ago

BRIEF-Bone Therapeutics reports strong interim results from ALLOB phase IIa spinal fusion study

Sept 14 (Reuters) - BONE THERAPEUTICS:

* REG-BONE THERAPEUTICS SA : REPORTS STRONG INTERIM RESULTS FROM ALLOB® PHASE IIA SPINAL FUSION STUDY

* ‍SIGNIFICANT CLINICAL AND RADIOLOGICAL IMPROVEMENTS COMPARED TO BASELINE​

* ‍RESULTS PAVE WAY FOR FUTURE DEVELOPMENT IN GROWING AND SIGNIFICANT LUMBAR SPINAL FUSION MARKET​

* RECRUITMENT WILL CONTINUE IN STUDY TO ALLOW COMPANY TO PERFORM A FINAL ANALYSIS ON 32 PATIENTS

* ‍RESULTS FOR FIRST 15 PATIENTS IN STUDY SHOW EVIDENCE OF SUCCESSFUL FUSION​

* COMPLETION OF RECRUITMENT EXPECTED BY END OF 2017 OR EARLY 2018.

* ‍RESULTS FOR FIRST 15 PATIENTS IN STUDY SHOW IMPORTANT CLINICAL IMPROVEMENTS IN FUNCTION AND PAIN AFTER 12-MONTH FOLLOW-UP PERIOD.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below